Choosing wisely for young women with breast cancer: Surgery

Choosing Wisely for young women with breast cancer: Radiotherapy

Choosing Wisely for young women with breast cancer: Medical therapy

ESMO 2024: Highlights and analysis

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer

Radiation therapy for breast cancer can be safely shortened by changing technique

No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC

Mutational-based treatment approach may significantly improve outcomes in pretreated patients with metastatic solid tumours

TNBC: Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OS compared to neoadjuvant chemo alone

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer

Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC